Novo Nordisk has become Europe’s most valuable company due to soaring demand for its weight-loss-aiding drugs Wegovy, Semaglutide, and Ozempic. But as the effective backbone of the Danish economy goes from strength to strength, it now faces the daunting task of making sure the country’s residents aren’t left behind.
Novo Nordisk has had a major factory in Kalundborg, about an hour outside the Danish capital of Copenhagen, for 55 years.
